Stress Management and Resiliency Training for Physicians

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03570853
Collaborator
(none)
160
2
2
35.7
80
2.2

Study Details

Study Description

Brief Summary

This study is to evaluate the effects of the SMART-3RP (Stress Management and Resiliency Training Relaxation Response Resiliency Program) on physician and academic faculty well-being, perceived stress, burnout, compassion, and job satisfaction.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: SMART-3RP
N/A

Detailed Description

Burnout is a serious problem in healthcare, resulting in absenteeism, decreased job satisfaction, decreased empathy, anxiety, depression, increased medical errors and decreased patient satisfaction. A growing number of studies have demonstrated that programs incorporating mind-body practices increase resilience in healthcare providers and can reduce burnout and perceived stress while increasing empathy. The Benson-Henry Institute for Mind Body Medicine (BHI) has developed a clinical program for patients known as the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP or SMART Program for short). This study is to evaluate the effect of the SMART-3RP on physician and academic faculty well-being, perceived stress, burnout, compassion, and job satisfaction.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Stress Management and Resiliency Training for Physicians
Actual Study Start Date :
Jul 9, 2018
Anticipated Primary Completion Date :
Jun 30, 2021
Anticipated Study Completion Date :
Jun 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Participants will receive the 8-week SMART-3RP intervention within a few weeks of enrolling in the study.

Behavioral: SMART-3RP
This is an 8-week, multimodal resiliency program that targets stress with 4 main components: mind-body skills (participants learn a variety of meditation techniques, mini relaxations, walking meditation, and yoga), traditional stress management techniques, healthy lifestyle behaviors (sleep, exercise, nutrition, and social support), and cognitive reappraisal and adaptive coping skills (borrowed from cognitive behavioral therapy, acceptance and commitment therapy, and positive psychology). The program consists of 8, 1.5 hour sessions.
Other Names:
  • Stress Management and Resiliency Training Relaxation Response Resiliency Program
  • Stress Management and Resiliency Training Program (SMART Program)
  • No Intervention: No Intervention

    Participants will not receive the SMART-3RP program and will only complete study questionnaires..

    Outcome Measures

    Primary Outcome Measures

    1. Change in perceived stress: pre-program vs. post-program [Approximately 2 months]

      Change in score on the perceived stress scale - 10 item instrument (PSS-10) from baseline to completion of the group.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Physicians and academic faculty of Brigham and Women's Hospital and Newton-Wellesley Hospital
    Exclusion Criteria:
    • None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Brigham and Women's Hospital Boston Massachusetts United States 02115
    2 Newton Wellesley Hospital Newton Massachusetts United States 02462

    Sponsors and Collaborators

    • Massachusetts General Hospital

    Investigators

    • Principal Investigator: John Denninger, MD, PhD, Benson-Henry Institute for Mind Body Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    John W. Denninger, MD, PhD, Director of Research, Massachusetts General Hospital
    ClinicalTrials.gov Identifier:
    NCT03570853
    Other Study ID Numbers:
    • 2018P000836
    First Posted:
    Jun 27, 2018
    Last Update Posted:
    Feb 24, 2021
    Last Verified:
    Feb 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by John W. Denninger, MD, PhD, Director of Research, Massachusetts General Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 24, 2021